"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania,
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4470-4477. doi: 10.26355/eurrev_202107_26238.
Liver cancer is one of the widest spread malignancies in the world and its incidence is still on the rise. The surgical resection of liver cancer has become a widely performed procedure with considerably improved outcomes, low mortality rate, transfusions, and post-op bed stay.
Our goal with this paper was to conduct a narrative review of the literature in regard to the surgical treatment of hepatocellular carcinoma (HCC).
There are various modalities of treatment for the HCC, e.g., hepatic resection, LT, or radiofrequency ablation (RFA) - the selection of a specific treatment regimen plays a decisive role in the survival rate of the patient and this, in turn, is guided by factors like size and distribution of lesion and the stage of malignancy. A more efficient patient selection for each treatment increases the survival rate of the patients in each subgroup.
Surgical procedures play a crucial role in treatment of hepatocellular carcinoma as part of a multimodal therapy.
肝癌是世界上分布最广泛的恶性肿瘤之一，其发病率仍在上升。肝癌的手术切除已成为一种广泛开展的手术，其结果显著改善，死亡率、输血率和术后卧床时间均较低。
我们撰写本文的目的是对肝癌的外科治疗进行文献综述。
肝癌的治疗方法有多种，例如肝切除术、肝移植或射频消融（RFA）-特定治疗方案的选择对患者的生存率起着决定性作用，而这反过来又受到病变的大小和分布以及恶性程度等因素的影响。对每种治疗方法进行更有效的患者选择可提高每个亚组患者的生存率。
外科手术作为多模式治疗的一部分，在治疗肝细胞癌中起着关键作用。
